NanoViricides announces $3.8M registered direct offering; shares down
at seekingalpha.com (Fri, 24-Jul 8:23 AM)
NV-387’s Unique Position: NanoViricides’ Antiviral Candidate Could Fill the Deadly Ebola Treatment Gap
Market Chameleon (Wed, 27-May 10:32 AM)
